Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Founded in 2017, Gyroscope Therapeutics is backed by investors that include Cambridge Innovation Capital and Syncona Partners LLP and is headquartered in Stevenage.
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
